Description
The uses of Betasalic ointment may include:
- Inflammatory skin conditions
- Hyperkeratotic skin disorders
- Scaling skin conditions
- Acne and pimples
- Calluses and corns
Sh4,500.00
Betasalic ointment is a combination medication that contains two active ingredients: Betamethasone (a corticosteroid) and Salicylic acid (a keratolytic). It is commonly used to treat various skin conditions.
The uses of Betasalic ointment may include:
Settings | BEZIC OINTMENT 30gm remove | Acetazolamide Tablets 250mg remove | Artemether Syrup 60ml ARH-L remove | AMBROX SYRUP 100ml remove | AMBROSAN SYRUP AMBROXOL 100ML remove | ACTINAC PLUS TABS remove |
---|---|---|---|---|---|---|
Image | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
SKU | ||||||
Rating | ||||||
Price | Sh4,500.00 | Sh20,000.00 | Sh4,000.00 | Sh3,000.00 | Sh3,000.00 | Sh4,000.00 |
Stock | ||||||
Availability | ||||||
Add to cart | ||||||
Description | Betasalic ointment is a combination medication that contains two active ingredients: Betamethasone (a corticosteroid) and Salicylic acid (a keratolytic). It is commonly used to treat various skin conditions. |
| Ambroxol syrup is a medicine used to treat respiratory conditions that involve the production of excess mucus, such as bronchitis, chronic obstructive pulmonary disease (COPD), asthma, and other conditions that affect the lungs and airways. | |||
Content | The uses of Betasalic ointment may include:
| Acetazolamide 250mg Tablets contain the active substance Acetazolamide. This belongs to a group of medicines known as carbonic anhydrase inhibitors. | Artemether(Coartem) generic Artemether is a potent and quick-acting antimalarial agent, used for treating chloroquine-resistant falciparum malaria, including cerebral malaria. | The main uses of Ambroxol syrup include:
| Prescribed for various respiratory diseases such as
| It is used to reduce pain and inflammation in conditions like:
|
Weight | ||||||
Dimensions | N/A | N/A | N/A | N/A | N/A | N/A |
Additional information |
Reviews
There are no reviews yet.